Nitrogen

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for use in specific medical situations where the administration of Nitrogen is deemed necessary. It is essential that this drug be administered only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with Nitrogen administration, which may render it contraindicated in certain circumstances. There are no specific teratogenic or nonteratogenic effects reported for this drug.

Dosage and Administration

Nitrogen is administered via inhalation, utilizing a volume of 995 mL in a 1 L container. The administration of Nitrogen must be conducted exclusively by or under the supervision of a licensed practitioner who possesses experience in the use and administration of this gas.

Healthcare professionals are required to have a thorough understanding of the indications, effects, dosages, methods, frequency, and duration of administration prior to initiating treatment. This ensures safe and effective use of Nitrogen in clinical settings.

Contraindications

There are no specific contraindications identified for this product. However, it is essential to adhere to the following precautions to ensure safe handling and use:

• Do not handle the product until all safety precautions have been read and understood.

• Use and store the product exclusively outdoors or in a well-ventilated area to minimize inhalation risks.

• Utilize only equipment that is rated for cylinder pressure to prevent potential hazards.

• Protect the product from sunlight when ambient temperatures exceed 52°C (125°F) to avoid degradation or safety issues.

Warnings and Precautions

Administration of Nitrogen may pose significant hazards and is contraindicated in certain situations. It is imperative that this substance is used solely by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. This practitioner must be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Warnings

Nitrogen is classified as a refrigerated gas, which may lead to rapid suffocation if not handled properly. Additionally, it is stored under pressure, presenting a risk of explosion if exposed to heat. The gas can displace oxygen in the environment, further increasing the risk of rapid suffocation.

General Precautions

Prior to handling Nitrogen, it is essential that all safety precautions are thoroughly read and understood. The gas should only be used and stored outdoors or in a well-ventilated area to mitigate risks. Personal protective equipment, including cold insulating gloves, a face shield, and eye protection, must be worn at all times during handling.

A backflow preventive device should be utilized in the piping to prevent any potential hazards. Connections must not be changed or forced, and the valve should be closed after each use and when the container is empty. It is crucial to maintain the container in an upright position at all times. Users are advised to read and adhere to the Safety Data Sheet (SDS) before use to ensure safe handling practices.

Emergency Medical Help Instructions

In the event of inhalation, it is critical to remove the affected individual to fresh air and ensure they are comfortable for breathing. Medical advice or attention should be sought immediately.

Stop Taking and Call Your Doctor Instructions

If Nitrogen comes into contact with the skin, it is important to thaw any frosted areas using lukewarm water without rubbing the affected area. Immediate medical advice or attention should be obtained to address any potential injuries.

Side Effects

Patients should be aware of the potential for serious adverse reactions associated with the use of this product. Notably, there is a warning that the product may displace oxygen, which can lead to rapid suffocation. This risk necessitates immediate action if exposure occurs.

In the event of inhalation, it is crucial to remove the affected individual to fresh air and ensure they are comfortable for breathing. Medical advice and attention should be sought promptly to address any complications that may arise from exposure.

These precautions are essential for ensuring the safety and well-being of patients and should be communicated clearly to all individuals involved in the use of this product.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Administration of Nitrogen in pediatric patients may pose significant risks and is contraindicated unless performed by or under the supervision of a licensed practitioner experienced in its use. This practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Pediatric patients are at particular risk due to the nature of Nitrogen as a refrigerated gas, which may cause rapid suffocation. Additionally, the gas is stored under pressure, presenting a risk of explosion if heated and the potential to displace oxygen, further increasing the risk of rapid suffocation.

In the event of inhalation, immediate action is required: the affected individual should be removed to fresh air and kept comfortable for breathing, followed by obtaining medical advice or attention.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment.

Lactation

There are no specific statements regarding the use of this medication in nursing mothers or its effects during lactation. Additionally, there is no available data on the excretion of this medication in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the absence of information when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, including airway management, oxygen supplementation, and intravenous fluids.

If the specific agent involved in the overdose is known, appropriate antidotes or specific treatments should be administered as indicated. Continuous monitoring of the patient’s condition is crucial, and healthcare providers should be prepared to manage complications that may arise.

In all cases of suspected overdose, it is advisable to contact a poison control center or consult relevant clinical guidelines for further management recommendations.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrogen may pose hazards or be contraindicated. It is essential that Nitrogen is used only by or under the supervision of a licensed practitioner who is experienced in its use and administration. Patients should be informed that the practitioner must be familiar with the indications, effects, dosages, methods, frequency and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Providers must emphasize the warning regarding the presence of refrigerated gas, which may cause rapid suffocation. Patients should be instructed not to handle Nitrogen until all safety precautions have been thoroughly read and understood. It is critical to use and store Nitrogen only outdoors or in a well-ventilated area. Patients should wear cold insulating gloves, a face shield, and eye protection during handling. Additionally, the use of a back flow preventive device in the piping is recommended. Patients must be cautioned against changing or forcing connections and should close the valve after each use and when the container is empty. It is important to always keep the container in an upright position and to read and follow the Safety Data Sheet (SDS) prior to use.

In the event of an emergency, healthcare providers should instruct patients on first aid measures. If Nitrogen is inhaled, patients should be removed to fresh air and kept comfortable for breathing. If Nitrogen comes into contact with the skin, patients should thaw any frosted areas with lukewarm water without rubbing the affected area and seek immediate medical advice or attention.

Furthermore, providers should inform patients that Nitrogen contains gas under pressure, which may explode if heated and can displace oxygen, leading to rapid suffocation. The same safety precautions apply: handling should only occur after all safety measures have been read and understood, and it should be used and stored in well-ventilated areas. Patients should be reminded to use only equipment rated for cylinder pressure, close the valve after each use, and protect the container from sunlight when ambient temperatures exceed 52°C (125°F). Again, reading and following the Safety Data Sheet (SDS) is crucial before use.

In case of inhalation, patients should be advised to remove themselves to fresh air and seek medical advice or attention as necessary.

Storage and Handling

The product is supplied in a container that must be kept in an upright position at all times. It is essential to store and use the product exclusively outdoors or in a well-ventilated area to ensure safety. When handling the product, personnel should wear cold insulating gloves, a face shield, and eye protection to mitigate risks.

To maintain product integrity, it is crucial to protect it from sunlight when the ambient temperature exceeds 52°C (125°F). After each use and when the container is empty, the valve should be closed to prevent any potential leaks. Additionally, a backflow preventive device must be utilized in the piping to ensure safe operation.

Before handling the product, all safety precautions must be thoroughly read and understood. It is also imperative to consult and follow the Safety Data Sheet (SDS) prior to use to ensure compliance with safety guidelines.

Additional Clinical Information

The route of administration for the product is via respiratory inhalation. Clinicians should be aware that the administration of Nitrogen may pose hazards or be contraindicated, and it should only be used under the supervision of a licensed practitioner experienced in its use.

Patient counseling is critical, as the product contains refrigerated gas, which may cause rapid suffocation. It is essential to read and understand all safety precautions before handling. Users should operate in well-ventilated areas, wear appropriate protective gear, and follow specific storage and usage guidelines, including keeping the container upright and closing the valve after use. In case of inhalation, individuals should be moved to fresh air, while skin contact should be treated by thawing affected areas with lukewarm water without rubbing. Immediate medical attention is advised for both scenarios.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by 801576526. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)